GC Therapeutics

GC Therapeutics is a biopharmaceutical company aimed at expanding and unlocking the next generation of cell therapy-based drugs. GCTx's induced pluripotent stem cell (iPSC) programming platform TFome™ (tee-eff-ome) integrates the latest advances in synthetic biology, gene editing, cell engineering, and machine learning to overcome the therapeutic development and scaling complexities associated with cell therapies and improve patient access across a wide range of disease areas. GCTx’s initial focus is on developing first-in-class and best-in-class cell therapies for gastrointestinal, neurological, and immune diseases.